1 year return (CAGR)
-28.43%
Revance Therapeutics, Inc. Exchange (NASDAQ, USD)
RVNC
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-35.37%
5 year return (CAGR)
-30.94%
10 year return (CAGR)
-13.79%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
381.02M
Price/Sales
1.54
Ent value
947.03M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-0.57%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 3.65 |
| Daily high | 3.65 |
| Daily low | 3.65 |
| Daily Volume | 0K |
| 1y analyst estimate | 9.47 |
| Beta | 0.95 |
| EPS (TTM) | -1.74 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RVNC | S&P500 | |
| Current price drop from All-time high | -91.05% | -0.56% |
| Highest price drop | -94.26% | -56.47% |
| Date of highest drop | 26 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -48.40% | -10.68% |
| Avg time to new high | 213 days | 12 days |
| Max time to new high | 2323 days | 1805 days |
News
No items found